Literature DB >> 18939929

Stem cell delivery by lumbar puncture as a therapeutic alternative to direct injection into injured spinal cord.

Birgit Neuhuber1, Alissa L Barshinger, Courtney Paul, Jed S Shumsky, Takahiko Mitsui, Itzhak Fischer.   

Abstract

OBJECT: Using cellular transplants to treat spinal cord injury is a promising therapeutic strategy, but transplants grafted directly into the injury site can further damage the already compromised cord. To avoid additional trauma and to simplify translation to the clinic, it is advantageous to use less invasive delivery methods.
METHODS: The authors compared the efficacy of intrathecal cell delivery at the lumbar region (lumbar puncture [LP]) to direct injection into a thoracic contusion injury using a mixed population of lineage-restricted neural precursor cells.
RESULTS: Direct injection resulted in a higher volume of neural precursor cells located throughout the injury site, whereas fewer LP-delivered cells accumulated at the dorsal aspect of the injured cord. Both grafting methods were neuroprotective, resulting in reduction of injury size and greater tissue sparing compared with controls. Functional recovery was evaluated by assessing motor and bladder function. Animals that received cells via direct injection performed significantly better in the open-field locomotor test than did operated controls, while LP-treated animals showed intermediate recovery of function that did not differ statistically from that of either operated controls or directly injected animals. Bladder function, however, was significantly improved in both directly injected and LP-treated animals.
CONCLUSION: Grafting of stem cells via LP resulted in localized accumulation of cells at the injury site, neuroprotection, and modest recovery of function. Further optimization of the LP procedure by increasing the number of cells that are delivered and determining the optimal delivery schedule may further improve recovery to levels comparable to direct injection.

Entities:  

Mesh:

Year:  2008        PMID: 18939929     DOI: 10.3171/SPI.2008.9.10.390

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  13 in total

1.  Acute administration of AMPA/Kainate blocker combined with delayed transplantation of neural precursors improves lower urinary tract function in spinal injured rats.

Authors:  Takahiko Mitsui; Birgit Neuhuber; Itzhak Fischer
Journal:  Brain Res       Date:  2011-08-22       Impact factor: 3.252

2.  Sponge-mediated lentivirus delivery to acute and chronic spinal cord injuries.

Authors:  Aline M Thomas; Jaime L Palma; Lonnie D Shea
Journal:  J Control Release       Date:  2015-02-24       Impact factor: 9.776

Review 3.  A systematic review of cellular transplantation therapies for spinal cord injury.

Authors:  Wolfram Tetzlaff; Elena B Okon; Soheila Karimi-Abdolrezaee; Caitlin E Hill; Joseph S Sparling; Jason R Plemel; Ward T Plunet; Eve C Tsai; Darryl Baptiste; Laura J Smithson; Michael D Kawaja; Michael G Fehlings; Brian K Kwon
Journal:  J Neurotrauma       Date:  2010-04-20       Impact factor: 5.269

Review 4.  Does the preclinical evidence for functional remyelination following myelinating cell engraftment into the injured spinal cord support progression to clinical trials?

Authors:  Scott A Myers; Andrew N Bankston; Darlene A Burke; Sujata Saraswat Ohri; Scott R Whittemore
Journal:  Exp Neurol       Date:  2016-04-13       Impact factor: 5.330

Review 5.  Clinical application of stem cell therapy in neurogenic bladder: a systematic review and meta-analysis.

Authors:  Hanieh Salehi-Pourmehr; Ozra Nouri; Amirreza Naseri; Leila Roshangar; Reza Rahbarghazi; Saeed Sadigh-Eteghad; Javad Mahmoudi; Hadi Mostafaei; M Reza Roshandel; Leila Hoseini; Nasrin Abolhasanpour; Ali Mostafaei; Sakineh Hajebrahimi; Hashim Hashim
Journal:  Int Urogynecol J       Date:  2021-11-12       Impact factor: 1.932

6.  Neural stem cell therapy of foetal onset hydrocephalus using the HTx rat as experimental model.

Authors:  Roberto Henzi; Karin Vío; Clara Jara; Conrad E Johanson; James P McAllister; Esteban M Rodríguez; Montserrat Guerra
Journal:  Cell Tissue Res       Date:  2020-02-17       Impact factor: 5.249

7.  Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome.

Authors:  S Oraee-Yazdani; M Hafizi; A Atashi; F Ashrafi; A-S Seddighi; S M Hashemi; A Seddighi; M Soleimani; A Zali
Journal:  Spinal Cord       Date:  2015-11-03       Impact factor: 2.772

8.  Combination therapy of stem cell derived neural progenitors and drug delivery of anti-inhibitory molecules for spinal cord injury.

Authors:  Thomas S Wilems; Jennifer Pardieck; Nisha Iyer; Shelly E Sakiyama-Elbert
Journal:  Acta Biomater       Date:  2015-09-15       Impact factor: 8.947

Review 9.  Evaluation and Management of Neurogenic Bladder: What Is New in China?

Authors:  Limin Liao
Journal:  Int J Mol Sci       Date:  2015-08-10       Impact factor: 5.923

10.  Optimal time for subarachnoid transplantation of neural progenitor cells in the treatment of contusive spinal cord injury.

Authors:  Yan Liu; Ying Zhou; Chunli Zhang; Feng Zhang; Shuxun Hou; Hongbin Zhong; Hongyun Huang
Journal:  Neural Regen Res       Date:  2013-02-15       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.